Molecular Insight Pharmaceuticals, Inc. 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed Jun 20, 2008
Insider Transaction Report
Form 4
Barrett John A
Sr. V.P. of Preclinical Dev
Transactions
- Award
Employee Stock Option (right to buy)
2008-06-18+15,000→ 15,000 totalExercise: $6.80From: 2009-04-08Exp: 2018-04-08→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in four equal annual installments of 3,750 shares each, beginning on April 8, 2009.